122 related articles for article (PubMed ID: 1233373)
1. Immunologic factors in experimental metastases formation.
Fidler IJ
Int J Radiat Oncol Biol Phys; 1975; 1(1-2):93-6. PubMed ID: 1233373
[No Abstract] [Full Text] [Related]
2. Metastatic spread and "escape" from the immune defenses of the host.
Alexander P
Natl Cancer Inst Monogr; 1976 Nov; 44():125-9. PubMed ID: 1025472
[TBL] [Abstract][Full Text] [Related]
3. The role of circulating antibody in the control of metastases.
Lewis MG
J Clin Pathol Suppl (R Coll Pathol); 1974; 7():83-93. PubMed ID: 4598354
[No Abstract] [Full Text] [Related]
4. [Recent advances in the study of metastases].
Carter RL
Recenti Prog Med; 1973 May; 54(5):404-21. PubMed ID: 4581375
[No Abstract] [Full Text] [Related]
5. Differences in cell surface antigens of tumor metastases and those of the local tumor.
Fogel M; Gorelik E; Segal S; Feldman M
J Natl Cancer Inst; 1979 Mar; 62(3):585-8. PubMed ID: 84091
[TBL] [Abstract][Full Text] [Related]
6. The possible biological significance of Fc receptors on mammalian lymphocytes and tumor cells.
Kerbel RS; Davies AJ
Cell; 1974 Oct; 3(2):105-112. PubMed ID: 4214616
[No Abstract] [Full Text] [Related]
7. [The influence of humoral immune mechanisms on metastasizing tumors in humans (author's transl)].
Lewis MG; Phillips TM; Rowden G; Hammer C
MMW Munch Med Wochenschr; 1977 Oct; 119(43):1393-6. PubMed ID: 412076
[TBL] [Abstract][Full Text] [Related]
8. Control of tumor growth in mice by thoracic duct drainage: relationship to blocking factor in lymph.
Noonan FP; Gardner MA; Clunie GJ; Isbister WH; Halliday WJ
Int J Cancer; 1974 May; 13(5):640-9. PubMed ID: 4843878
[No Abstract] [Full Text] [Related]
9. [Tumor immunology].
Cerni CM
Subsid Med; 1974; 2():21-5. PubMed ID: 4606048
[No Abstract] [Full Text] [Related]
10. [Why does a tumor grow?].
Dosne Pasqualini C; Laguens RP; Colmerauer ME; Segal A
Medicina (B Aires); 1974; 34(6):659-64. PubMed ID: 4617837
[No Abstract] [Full Text] [Related]
11. Effects on tumor growth in vivo by manipulation of the tumor immune response.
Sjögren HO
Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
[No Abstract] [Full Text] [Related]
12. Macrophages and cancer metastasis.
Fidler IJ; Poste G
Adv Exp Med Biol; 1982; 155():65-75. PubMed ID: 6984285
[TBL] [Abstract][Full Text] [Related]
13. Recurrent and metastatic malignant disease: immunological considerations.
Carter RL
Proc R Soc Med; 1974 Sep; 67(9):852-4. PubMed ID: 4610589
[No Abstract] [Full Text] [Related]
14. Definitive evidence that natural killer (NK) cells inhibit experimental tumor metastases in vivo.
Hanna N; Burton RC
J Immunol; 1981 Nov; 127(5):1754-8. PubMed ID: 7299115
[TBL] [Abstract][Full Text] [Related]
15. Immune responses to tumor antigens and their clinical applications.
Balch CM
Surgery; 1986 Sep; 100(3):562-71. PubMed ID: 3488601
[No Abstract] [Full Text] [Related]
16. Tumour antigen heterogeneity within melanoma metastases--an evaluation by immunohistochemistry.
Ingvar C; Jakobsson B; Brodin T; Jönsson PE; Strand SE
Anticancer Res; 1990; 10(1):219-23. PubMed ID: 2334131
[TBL] [Abstract][Full Text] [Related]
17. Macrophage content of tumours in relation to metastatic spread and host immune reaction.
Eccles SA; Alexander P
Nature; 1974 Aug; 250(5468):667-9. PubMed ID: 4546859
[No Abstract] [Full Text] [Related]
18. Immunologic aspects of cancer.
Sophocles AM; Nadler SH
Surg Gynecol Obstet; 1971 Aug; 133(2):321-31. PubMed ID: 4935594
[No Abstract] [Full Text] [Related]
19. Cellular and humoral immune interactions during neoplastic development.
Baldwin RW; Bowen JG; Embleton MJ; Price MR; Robins RA
Johns Hopkins Med J Suppl; 1974; 3():393-407. PubMed ID: 4371716
[No Abstract] [Full Text] [Related]
20. Circulating lymphocytes and the spread of myeloma. Review of the evidence.
Warner TF; Krueger RG
Lancet; 1978 Jun; 1(8075):1174-6. PubMed ID: 77943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
